Multiple Australian outlets report on a clear aligner business that markets its product heavily online and generates revenue despite limited regulatory scrutiny for the item it sells. The reports say the aligners are classified by the Therapeutic Goods Administration (TGA) as one of thousands of medical devices considered so low-risk that they receive minimal oversight. The outlets state the device falls within a broader category of more than 28,000 medical devices the regulator deems to be low risk and therefore “barely” scrutinized.
The articles describe how the product is promoted primarily through social media marketing, and they reference reported harms associated with the product, including dental problems such as broken teeth and cases described as “locked jaws.” While the sources differ in their framing and emphasis, they consistently link the company’s commercial success with the regulatory approach to similar devices and the scale of low-risk device classifications.
Overall, the coverage focuses on the contrast between online promotion and the regulatory category assigned to the product, along with alleged or reported outcomes for consumers.
